Form 4: ProPhase Labs CEO Ted Karkus Acquires 400,000 Stock Options
SEC Form 4
ProPhase Labs CEO and Chairman Ted Karkus reports the acquisition of 400,000 stock options on March 17, 2024.
Summary
- Ted William Karkus, CEO and Chairman of ProPhase Labs, Inc., filed a Form 4 on March 19, 2024, reporting a transaction.
- On March 17, 2024, Karkus acquired 400,000 options to buy common stock at an exercise price of $6.
- These options vest in four equal installments, with 25% vesting immediately and the remainder vesting annually over the next three years.
- The options expire on March 17, 2031.
- Following the transaction, Karkus beneficially owns 400,000 derivative securities (options).
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing related to stock option grants, which can be seen as a positive sign of aligning management interests with shareholders, but doesn't necessarily indicate a major shift in the company's outlook.
Positives
- The acquisition of stock options by the CEO could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Stakeholder Impact
- Shareholders may view the option grant as a sign of confidence from the CEO.
- Employees may be motivated by the CEO's increased stake in the company's success.
Key Dates
| Date | Description |
|---|---|
| 03/17/2024 | Date of the transaction: acquisition of stock options. |
| 03/17/2024 | Grant date and initial vesting date for 25% of the options. |
| 03/17/2031 | Expiration date of the options. |
| 03/19/2024 | Date the Form 4 was signed. |
Keywords
ProPhase Labs, Ted Karkus, stock options, Form 4, derivative securities, beneficial ownership, CEO, PRPH
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.